Cargando…

Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before–after design

INTRODUCTION: Vaccines against human papillomavirus (HPV) are the key to controlling cervical cancer in low/middle-income countries (LMICs) where incidence is highest, but there have been limited data from these settings on programme impact on HPV prevalence, and none in a population with endemic HI...

Descripción completa

Detalles Bibliográficos
Autores principales: Machalek, Dorothy, Rees, Helen, Chikandiwa, Admire, Munthali, Richard, Travill, Danielle, Mbulawa, Zizipho, Petoumenos, Kathy, Delany-Moretlwe, Sinead, Kaldor, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845310/
https://www.ncbi.nlm.nih.gov/pubmed/35144959
http://dx.doi.org/10.1136/bmjopen-2021-059968
_version_ 1784651647844089856
author Machalek, Dorothy
Rees, Helen
Chikandiwa, Admire
Munthali, Richard
Travill, Danielle
Mbulawa, Zizipho
Petoumenos, Kathy
Delany-Moretlwe, Sinead
Kaldor, John
author_facet Machalek, Dorothy
Rees, Helen
Chikandiwa, Admire
Munthali, Richard
Travill, Danielle
Mbulawa, Zizipho
Petoumenos, Kathy
Delany-Moretlwe, Sinead
Kaldor, John
author_sort Machalek, Dorothy
collection PubMed
description INTRODUCTION: Vaccines against human papillomavirus (HPV) are the key to controlling cervical cancer in low/middle-income countries (LMICs) where incidence is highest, but there have been limited data from these settings on programme impact on HPV prevalence, and none in a population with endemic HIV infection. Furthermore, for many LMICs, the currently recommended two-dose schedule is difficult to deliver at scale, so there is mounting interest in a single-dose schedule. METHODS AND ANALYSIS: The Human Papillomavirus One and Two-Dose Population Effectiveness Study is a hybrid impact evaluation of the national South African HPV vaccination programme, which has targeted grade 4 girls aged at least 9 years in public schools with two doses of vaccine since 2014, and a single-dose vaccine ‘catch-up’ programme delivered in one district in 2019. Impacts of both schedules on the prevalence of type-specific HPV infection will be measured using repeat cross-sectional surveys in adolescent girls and young women aged 17–18 years recruited at primary healthcare clinics in the four provinces. A baseline survey in 2019 measured HPV prevalence in the cohort who were ineligible for vaccination because they were already above the target age or grade under either the national programme or the single-dose programme in the selected district. HPV prevalence surveys are repeated in 2021 in the selected district, and in 2023 in all four provinces. We will calculate prevalence ratios to compare the prevalence of HPV types 16 and 18 in the single-dose (2021) and two-dose (2023) cohorts, with the vaccine-ineligible (2019) cohort. ETHICS AND DISSEMINATION: The project was approved by the University of the Witwatersrand Human Research Ethics Committee (HREC #181005), and the University of New South Wales HREC (#181-005). Findings will be disseminated through peer-reviewed journals, scientific meetings, reports and community forums.
format Online
Article
Text
id pubmed-8845310
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88453102022-03-01 Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before–after design Machalek, Dorothy Rees, Helen Chikandiwa, Admire Munthali, Richard Travill, Danielle Mbulawa, Zizipho Petoumenos, Kathy Delany-Moretlwe, Sinead Kaldor, John BMJ Open Infectious Diseases INTRODUCTION: Vaccines against human papillomavirus (HPV) are the key to controlling cervical cancer in low/middle-income countries (LMICs) where incidence is highest, but there have been limited data from these settings on programme impact on HPV prevalence, and none in a population with endemic HIV infection. Furthermore, for many LMICs, the currently recommended two-dose schedule is difficult to deliver at scale, so there is mounting interest in a single-dose schedule. METHODS AND ANALYSIS: The Human Papillomavirus One and Two-Dose Population Effectiveness Study is a hybrid impact evaluation of the national South African HPV vaccination programme, which has targeted grade 4 girls aged at least 9 years in public schools with two doses of vaccine since 2014, and a single-dose vaccine ‘catch-up’ programme delivered in one district in 2019. Impacts of both schedules on the prevalence of type-specific HPV infection will be measured using repeat cross-sectional surveys in adolescent girls and young women aged 17–18 years recruited at primary healthcare clinics in the four provinces. A baseline survey in 2019 measured HPV prevalence in the cohort who were ineligible for vaccination because they were already above the target age or grade under either the national programme or the single-dose programme in the selected district. HPV prevalence surveys are repeated in 2021 in the selected district, and in 2023 in all four provinces. We will calculate prevalence ratios to compare the prevalence of HPV types 16 and 18 in the single-dose (2021) and two-dose (2023) cohorts, with the vaccine-ineligible (2019) cohort. ETHICS AND DISSEMINATION: The project was approved by the University of the Witwatersrand Human Research Ethics Committee (HREC #181005), and the University of New South Wales HREC (#181-005). Findings will be disseminated through peer-reviewed journals, scientific meetings, reports and community forums. BMJ Publishing Group 2022-02-10 /pmc/articles/PMC8845310/ /pubmed/35144959 http://dx.doi.org/10.1136/bmjopen-2021-059968 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Infectious Diseases
Machalek, Dorothy
Rees, Helen
Chikandiwa, Admire
Munthali, Richard
Travill, Danielle
Mbulawa, Zizipho
Petoumenos, Kathy
Delany-Moretlwe, Sinead
Kaldor, John
Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before–after design
title Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before–after design
title_full Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before–after design
title_fullStr Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before–after design
title_full_unstemmed Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before–after design
title_short Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before–after design
title_sort impact of one and two human papillomavirus (hpv) vaccine doses on community-level hpv prevalence in south african adolescent girls: study protocol and rationale for a pragmatic before–after design
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845310/
https://www.ncbi.nlm.nih.gov/pubmed/35144959
http://dx.doi.org/10.1136/bmjopen-2021-059968
work_keys_str_mv AT machalekdorothy impactofoneandtwohumanpapillomavirushpvvaccinedosesoncommunitylevelhpvprevalenceinsouthafricanadolescentgirlsstudyprotocolandrationaleforapragmaticbeforeafterdesign
AT reeshelen impactofoneandtwohumanpapillomavirushpvvaccinedosesoncommunitylevelhpvprevalenceinsouthafricanadolescentgirlsstudyprotocolandrationaleforapragmaticbeforeafterdesign
AT chikandiwaadmire impactofoneandtwohumanpapillomavirushpvvaccinedosesoncommunitylevelhpvprevalenceinsouthafricanadolescentgirlsstudyprotocolandrationaleforapragmaticbeforeafterdesign
AT munthalirichard impactofoneandtwohumanpapillomavirushpvvaccinedosesoncommunitylevelhpvprevalenceinsouthafricanadolescentgirlsstudyprotocolandrationaleforapragmaticbeforeafterdesign
AT travilldanielle impactofoneandtwohumanpapillomavirushpvvaccinedosesoncommunitylevelhpvprevalenceinsouthafricanadolescentgirlsstudyprotocolandrationaleforapragmaticbeforeafterdesign
AT mbulawazizipho impactofoneandtwohumanpapillomavirushpvvaccinedosesoncommunitylevelhpvprevalenceinsouthafricanadolescentgirlsstudyprotocolandrationaleforapragmaticbeforeafterdesign
AT petoumenoskathy impactofoneandtwohumanpapillomavirushpvvaccinedosesoncommunitylevelhpvprevalenceinsouthafricanadolescentgirlsstudyprotocolandrationaleforapragmaticbeforeafterdesign
AT delanymoretlwesinead impactofoneandtwohumanpapillomavirushpvvaccinedosesoncommunitylevelhpvprevalenceinsouthafricanadolescentgirlsstudyprotocolandrationaleforapragmaticbeforeafterdesign
AT kaldorjohn impactofoneandtwohumanpapillomavirushpvvaccinedosesoncommunitylevelhpvprevalenceinsouthafricanadolescentgirlsstudyprotocolandrationaleforapragmaticbeforeafterdesign
AT impactofoneandtwohumanpapillomavirushpvvaccinedosesoncommunitylevelhpvprevalenceinsouthafricanadolescentgirlsstudyprotocolandrationaleforapragmaticbeforeafterdesign